# 6645
An update this afternoon (h/t Catbird on FluTrackers) from the FDA indicating that tests have confirmed the presence of Exserohilum rostratum in unopened vials of methylprednisolone acetate prepared by the New England Compounding Center (NECC).
Update on Fungal Meningitis
- Archive of Updates on Fungal Meningitis Outbreak
- NECC press release and a complete list of the firm's compounded products
- FDA’s Drug Information Line: 855-543-DRUG (3784); email: druginfo@fda.hhs.gov
[10-18-2012] CDC and FDA have confirmed the presence of a fungus known as Exserohilum rostratumin unopened medication vials of preservative-free methylprednisolone acetate (80mg/ml) from one of the three implicated lots from NECC (Lot #08102012@51, BUD 2/6/2013). The laboratory confirmation further links steroid injections from these lots from NECC to the multistate outbreak of fungal meningitis and joint infections. Testing on the other two implicated lots of methylprednisolone acetate and other NECC injectables continues.
CDC and state health departments estimate that approximately 14,000 patients may have received injections with medication from three implicated lots of methylprednisolone and nearly 97% of these patients have been contacted for further follow-up.
Clinicians are also requested to report any suspected adverse events following use of these products to FDA's MedWatch program at 1-800-332-1088 or www.fda.gov/medwatch.
Health care professionals and patients may dial FDA’s Drug Information Line at 855-543-DRUG (3784) and press * to get the most recent information regarding the meningitis recall and speak directly to a pharmacist.
Related Post:
- CDC HAN Update On Fungal Meningitis Outbreak
- FDA: Ameridose Announces Voluntary Recall Of All Products
- FDA Statement On Conditions Reported At NECC Facility
- The Narrow Margin
- CDC/FDA: Multistate Fungal Meningitis Outbreak – Oct 15th
- CDC Update: Multi State Meningitis Outbreak – Oct 11th
- FDA Advice On Safe Use Of Neti Pots
- FDA Warning On Fake Adderall
- FDA Statement On Azithromycin & Cardiovascular Risks
- FDA Releases 2nd Edition Of the `Bad Bug Book’
- Kids, Colds, And OTC Meds
- FDA Approves 2011-2012 Seasonal Influenza Vaccines
- Because Everyday Is Fry Day
- Poll: Despite FDA Warning Parents Use OTC Cold Remedies For Kids Under 2
- FDA: Fluzone Vaccine Safety
- Salmonella-Related Egg Recall Expands
- Study: MLV Found In CFS Patients
- CDC Investigating Food-Related Typhoid Outbreak
- FDA Approves 2010-2011 Flu Vaccines
- FDA Farm Antibiotic Guidance Meets Resistance
- FDA Warns On Fake Tamiflu
- FDA Calls For Temporary Halt To Using Rotarix Vaccine
- FDA Warning On Extortion Scam
- Flu Email Scams
- MMWR: Invasive Meningococcal Disease Among MSM In New York City
- CDC HAN Update On Fungal Meningitis Outbreak
- Referral: McKenna On The Steroid-Linked Meningitis Outbreak
- CDC Update Of Fungal Meningitis Cases
- CDC HAN Advisory: Additional NECC Products Found Contaminated
- CDC: Laboratory Test Results From Meningitis Outbreak
- FDA Statement On Conditions Reported At NECC Facility
- CDC Fungal Meningitis Update – Oct. 26th
- CDC HAN Advisory & Updates On Fungal Meningitis
- CDC Fungal Meningitis Update – Oct 22nd
- CDC Fungal Meningitis Update – Oct 19th
- Revisiting An Earlier Fungal Meningitis Outbreak
- CDC Fungal Meningitis Update – Oct 18th
- Detailed Report On Fatal Meningitis Case
- CDC Fungal Meningitis Update – Oct 17th
- CDC/FDA: Multistate Fungal Meningitis Outbreak – Oct 15th
- MMWR: Multistate Outbreak Of Fungal Meningitis
- Multi-State Meningitis Outbreak – Oct 12th
- CDC Update: Multi State Meningitis Outbreak – Oct 11th
- CDC: Update On Fungal Meningitis Outbreak – Oct 10th
- CDC Updates On Fungal Meningitis Outbreak
- The Return Of Naegleria fowleri
- Referral: Maryn McKenna On Meningitis in first responders
Widget by [ Iptek-4u ]